| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8665 |
| Human Intestinal Absorption | HIA+ | 0.9830 |
| Caco-2 Permeability | Caco2+ | 0.8429 |
| P-glycoprotein Substrate | Non-substrate | 0.6399 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.5986 |
| Non-inhibitor | 0.5896 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8705 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7978 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8068 |
| CYP450 2D6 Substrate | Non-substrate | 0.8219 |
| CYP450 3A4 Substrate | Non-substrate | 0.6303 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5552 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9487 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8761 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5090 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6694 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5128 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9101 |
| Non-inhibitor | 0.9527 |
| AMES Toxicity | Non AMES toxic | 0.8779 |
| Carcinogens | Non-carcinogens | 0.8200 |
| Fish Toxicity | High FHMT | 0.9582 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9692 |
| Honey Bee Toxicity | High HBT | 0.8272 |
| Biodegradation | Not ready biodegradable | 0.8395 |
| Acute Oral Toxicity | III | 0.8439 |
| Carcinogenicity (Three-class) | Non-required | 0.6545 |